Cite

HARVARD Citation

    Chrischilles, E. et al. (2018). Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel System. Pharmacoepidemiology and drug safety. 27 (3), pp. 263-271. [Online]. 
  
Back to record